| 期 |
标题 |
文件 |
| 编号 4 (2012) |
Primenenie ingibitorov apf s tsel'yu korrektsii endotelial'noy disfunktsii u patsientov na raznoy stadii khronicheskoy bolezni pochek |
|
|
Fedoseev A., Kudryakova A., Smirnov V., Krutova T., Ovsyannikov K.
|
| 编号 3-4 (2016) |
The use of ketoacids in chronic kidney disease |
|
|
Batushin M.
|
| 卷 13, 编号 4 (2021) |
The use of a complex of ferric oxyhydroxide, sucrose and starch (Velforo 500) in patients on programmed hemodialysis in the routine practice of an outpatient dialysis center: results of a prospective randomized trial |
|
|
Artemov D.
|
| 编号 5 (2011) |
LONG-TERM SUSTAINED LOW EFFICIENCY DIALYSIS IN TREATMENT OF PATIENTS WITH CARDIORENAL SYNDROME |
|
|
Kutepov D., Popov A., Tsygankov E., Vershinina M.
|
| 卷 16, 编号 1 (2024) |
Application of kidney injury molecule-1 (KIM-1) for predicting urgent cardiovascular complications in acute cardiorenal syndrome |
|
|
Pivovarov D., Mikhailova Z.
|
| 编号 4 (2014) |
The drug Canephron in complex treatment of patients with acute gestational pyelonephritis |
|
|
Motin P., Pulbere S., Loctev A., Abud M., Atamanova E.
|
| 编号 3 (2009) |
Primenenie preparatov eritropoetina u bol'nykh terminal'noy pochechnoy nedostatochnost'yu, nakhodyashchikhsya na programmnom gemodialize (rezul'taty mul'titsentrovogo observatsionnogo issledovaniya) |
|
|
Khasabov N., Hasabov N.
|
| 编号 1 (2017) |
The use of Everolimus as a part of maintenance immunosuppressive therapy in patients with minimal renal transplant dysfunction: results of a prospective observational program (CRAD001ARU01) |
|
|
Prokopenko E., Stolyarevich E.
|
| 卷 11, 编号 4 (2019) |
Principles for the organization of renal replacement therapy in emergency medicine of the Moscow healthcare department |
|
|
Rey S., Vasin N., Marchenkov L., Kotenko O.
|
| 编号 6 (2010) |
Rehberg-Tareev test |
|
|
- -.
|
| 编号 1 (2009) |
Hyperfiltration in clinical practise |
|
|
Arutyunov G., Oganezova L., Arutyunov G., Oganezova L.
|
| 编号 1 (2014) |
Unresolver problem of calcium in phosphate-binding therapy of bone-mineral metabolism dis-turbances in patients with chronic kidney disease on program hemodialysis |
|
|
Khoroshilov S.
|
| 编号 4 (2015) |
The issue of resistant hypertension in chronic glomerulonephritis |
|
|
Milchakov K., Fomin V., Shvetsov M., Husnutdinova L.
|
| 编号 6 (2010) |
INFLAMMATORY CYTOKINES IN PATHOGENESIS, DIAGNOSIS AND TREATMENT OF DIABETIC NEPHROPATHY |
|
|
Bondar' I., Klimontov V., Simakova A.
|
| 卷 15, 编号 1 (2023) |
Pro-inflammatory cytokines and their participation in the development of cardiovascular calcification in patients with chronic kidney disease |
|
|
Mambetova A., Khutueva M., Tkhabisimova I.
|
| 编号 2 (2016) |
Predicting cardiovascular complications in patients in late post-acute coronary syndrome period considering the body water imbalance and renal dysfunction |
|
|
Golovinova E., Levitskaya E., Batyushin M., Khripun A., Gul’chenko V.
|
| 编号 2 (2016) |
Predicting Outcomes of Renal Transplantation |
|
|
Stolyar A., Budkar’ L., Solodushkin S.
|
| 编号 1 (2011) |
Influence of cardiovascular and renal risk factors on prognosis of coronary heart disease patients, undergone myocardial revascularization |
|
|
Batyushin M., Levitskaya E., Terent'ev V., Dyuzhikov A., Poddubnyy A.
|
| 编号 5 (2010) |
Prognostic determinants of chronic heart failure, complicated with renal disfunction |
|
|
BATYuShIN M., VRUBLEVSKAYa N., TERENT'EV V.
|
| 卷 16, 编号 1 (2024) |
Prognostic value of the Charlson comorbidity index in patients aged 60 years and older starting chronic dialysis treatment |
|
|
Kurylovich K., Komissarov K., Krasko O.
|
| 编号 1 (2019) |
Prognostic value of sarcopenia in patients with CKD |
|
|
Sokolova A., Dragunov D., Arutyunov G., Mitrokhin V.
|
| 编号 2 (2009) |
Russian registry of resistant arterial hypertension (REGATTA): study design |
|
|
Chazova I., Fomin V., Razuvaeva M., Vigdorchik A., Chazova I., Fomin V., Razuvaeva M., Vigdorchik A.
|
| 编号 6 (2013) |
Prolonged tacrolimus in renal transplant patients management |
|
|
Svistunov A., Fomin V.
|
| 卷 14, 编号 3 (2022) |
Prostanorm®: application and effectiveness of use in patients with ureteral stent catheter |
|
|
Rusanova E., Vasilenk I., Bychkova N., Erofeeva S., Schelkova V., Voskoboynikova A., Kolkhir V.
|
| 编号 5-6 (2012) |
Proteomic spectrum of the urine in patients with chronic glomerulonephritis |
|
|
Gassanov M., Batiushin M., Terent’ev V., Sadovnichaya N.
|
| 编号 1 (2014) |
Proteomic spectrum of the urine in nephropathy of different genesis |
|
|
Batiushin M., Bronovitskaya N., Gassanov M., Sarvilin I.
|
| 编号 2 (2019) |
Professor Richard Bright (1789-1858) - the founder of clinical nephrology and a prominent scientist (on the 230th anniversary of his birth) |
|
|
Morgoshiya T., Sergeeva G., Ryzhova A.
|
| 卷 14, 编号 2 (2022) |
Prevention of thromboembolic complications in patients with end-stage kidney disease and atrial fibrillation |
|
|
Abdullaev S., Igamberdieva R.
|
| 编号 1 (2009) |
Direct renin inhibitor aliskiren - new opportunities of kidney protection at hypertensive patients |
|
|
Chazova I., Fomin V., Pal'tseva E., Chazova I., Fomin V., Paltseva E.
|
| 编号 4 (2010) |
PRYaMOY INGIBITOR RENINA ALISKIREN - SAMOSTOYaTEL'NAYa STRATEGIYa KORREKTsII KARDIORENAL'NOGO SINDROMA PRI METABOLIChESKOM SINDROME I OZhIRENII |
|
|
Fomin V., Saginova E.
|
| 编号 3 (2010) |
Ways of modernization of chronic kidney disease classification |
|
|
Smirnov A., Dobronravov V., Kayukov I., Smirnov A., Dobronravov V., Kaukov I.
|
| 编号 2 (2009) |
Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease |
|
|
Kozlovskaya L., Fomin V., Moiseev S., Khamkhoeva M.
|
| 编号 4 (2010) |
PUTI POVYShENIYa KAChESTVA LEChENIYa BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu PRI KhRONIChESKOY BOLEZNI POChEK |
|
|
- -.
|
| 编号 4 (2011) |
KIDNEY DEVELOPMENT AND PROBLEMS OF PEDIATRIC nephrology |
|
|
- -.
|
| 卷 15, 编号 3 (2023) |
Development of ideas about urolithiasis |
|
|
Subotyalov M.
|
| 编号 4 (2017) |
Development of professional standards in the specialty "doctor-nephrologist" |
|
|
- -.
|
| 编号 2 (2018) |
Early markers for the development and progression of reflux nephropathy in children |
|
|
Zaykova N., Dlin V., Eremeeva A., Sinitsyna L., Korsunsky A., Revenko N.
|
| 卷 15, 编号 1 (2023) |
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus |
|
|
Zeinebekova A., Umarova A., Usmanova D., Turkara A., Kovalchuk V., Dyussenova S.
|
| 编号 1 (2019) |
Early stages of CKD: problems and prospects |
|
|
Dorofeeva E.
|
| 编号 3 (2018) |
Distribution of HLA-antigens among patients with chronic kidney disease |
|
|
Ramilieva I., Turganbekova A., Burkitbaev Z., Abdrakhmanova S., Baymukasheva D., Zhiburt E.
|
| 编号 3 (2010) |
Prevalence of diabetic nephropathy and chronic kidney disease in diabetes mellitus in Russian Federation |
|
|
Maslova O., Suntsov Y., Shestakova M., Kazakov I., Vikulova L., Sukhareva O., Martynov S., Maslova O., Suntsov Y., Shestakova M., Kazakova I., Vikulova L., Sukhareva O., Martynov S.
|
| 卷 16, 编号 3 (2024) |
Prevalence and diagnosis of autosomal dominant polycystic kidney disease |
|
|
Dzhalilzoda S.
|
| 卷 17, 编号 1 (2025) |
Prevalence and pathogenesis of kidney damage in non-alcoholic fatty liver disease – possibilities of early diagnostics using fluorescence organoscopy |
|
|
Lelyavina T., Galagudza M., Sonin D., Popov S., Guseinov R., Beshtoev A., Malyshev E.
|
| 卷 11, 编号 4 (2019) |
The prevalence, clinical and functional characteristics of chronic kidney disease in residents of urban and rural areas in the Kyrgyz Republic |
|
|
Murkamilov I.
|
| 编号 6 (2014) |
The prevalence of renal disease in patients with decompensation of chronic heart failure |
|
|
Arutyunov G., Dragunov D., Sokolova A., Arutyunov A.
|
| 卷 15, 编号 3 (2023) |
Prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease |
|
|
Sokolova A., Dragunov D., Arutyunov G.
|
| 编号 1 (2014) |
Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region |
|
|
Yarkova Ν., Borovkov N., Solov’ianova E., Filina L.
|
| 编号 3 (2014) |
Prevalence of decreased glomerular filtration rate in working-able population of krasnodar city |
|
|
Bolotova E., Samorodskaya I., Dudnikova A., Kartavenkov S.
|
| 编号 5-6 (2015) |
Prevalence, course and opportunities for correction of secondary hyperparathyroidism in dialysis patients |
|
|
Gerasimchuk R., Novokshonov K., Zemchenkov A.
|
| 卷 14, 编号 3 (2022) |
Prevalence of risk factors for cerebrovascular diseases in patients with end-stage renal disease |
|
|
Murkamilov I., Sabirov I., Murkamilova Z., Fomin V., Sabirova A., Yusupov F., Kudaibergenova I., Maanaev T.
|
| 卷 13, 编号 3 (2021) |
Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia |
|
|
Essaian A., Arutyunov G., Melikhov O.
|
| 编号 3 (2012) |
RASPROSTRANENNOST' KhRONIChESKOY BOLEZNI POChEK SREDI PATsIENTOV TERAPEVTIChESKOGO STATsIONARA |
|
|
Pigareva Y., Avdoshina S., Dmitrova T., Efremovtseva M., Tigay Z.
|
| 编号 3 (2012) |
RASPROSTRANENNOST' KhRONIChESKOY BOLEZNI POChEK U BOL'NYKh PSORIATIChESKIM ARTRITOM |
|
|
Rebrov A., Kargal'skaya O.
|
| 编号 3-4 (2016) |
Prevalence |
|
|
Dragunov D., Sokolova A., Latyshev T., Arutyunov G.
|
| 编号 5 (2010) |
FREQUENT PITFALLS IN ANTIHYPERTENSIVE THERAPY |
|
|
Fomin V., Panasyuk V.
|
| 编号 5-6 (2012) |
Urination disorders in women - an interdisciplinary problei |
|
|
Alyayev Y., Ishchenko A., Gadzhiyeva Z., Chushkov Y.
|
| 编号 3 (2011) |
SODIUM HOMEOSTASIS DISORDERS: THE MULTIDISCIPLINARY APPROACH |
|
|
- -.
|
| 卷 13, 编号 1 (2021) |
Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere |
|
|
Kalantar-Zadeh K., Li P., Tantisattamo E., Kumaraswami L., Liakopoulos V., Lui S., Ulasi I., Andreoli S., Balducci A., Dupuis S., Harris T., Hradsky A., Knight R., Kumar S., Ng M., Poidevin A., Saadi G., Tong A.
|
| 编号 3-4 (2016) |
Platelet reactivity in chronic obstructive pyelonephritis: role of adrenaline in the pathogenesis of complications |
|
|
Barinov E.
|
| 卷 15, 编号 2 (2023) |
Regional citrate anticoagulation with 4% sodium citrate |
|
|
Avetisyan E., Kostritsa N.
|
| 编号 1 (2010) |
REGRESSION OF ARTERIAL HYPERTENSION CAUSED BY BILATERAL FIBROMUSCULAR DYSPLASIA OF RENAL ARTERIES PREVIOUSLY INTERPRETED AS CHRONIC PYELONEPHRITIS, AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY |
|
|
Zakirova A., Karamova I., Valeev I., Berg A., Zagidullin I., Yarullina A., Zakirova A., Karamova I., Valeev I., Berg A., Zagidullin I., Yarullina A.
|
| 卷 15, 编号 2 (2023) |
Rare benign kidney tumors. Review of clinical cases |
|
|
Trushkin R., Isaev T., Medvedev P., Sokolov S., Parshin V., Manchenko O., Varyasin V., Berezhnaya E., Klementyeva T.
|
| 卷 15, 编号 3 (2023) |
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic. Terapevticheskii Arkhiv (Ter. Arkh.) |
|
|
Avdeev S., Chulanov V., Alekseeva E., Alyoshina O., Bereznikov A., Kotenko O., Lila A., Mutovina Z., Parovichnikova E., Fomina D., Frolova N., Shevchenko A.
|
| 卷 13, 编号 2 (2021) |
Resolution of the meeting of the working group on nephrology of the state duma health protection committee |
|
|
- -.
|
| 编号 3 (2018) |
Interdisciplinary Expert Council Resolution. Kidney transplantation in patients with atypical hemolytic-uremic syndrome: clinical and organizational-methodical aspects of patient management |
|
|
Kaabak M., Molchanova E., Nesterenko I., Pinchuk A., Prokopenko E., Stolyarevich E., Sushkov A., Tomilina N., Tsygin A., Emirova K., Babenko N.
|
| 编号 2 (2014) |
Resolution of advisory council of nephrologists |
|
|
- -.
|
| 编号 3 (2014) |
Expert Council Resolution for treatment optimization for atypical hemolytic-uremic syndrome |
|
|
- -.
|
| 卷 13, 编号 2 (2021) |
The results of 5-year experience in testing the glomerular filtration rate by the INVITRO laboratory in the territory of the Russian Federation |
|
|
Fadin D., Fedin V., Zingerman B., Kotenko O., Kargalskaya I.
|
| 编号 2 (2014) |
The results of the advisory council of experts «Place of calcimimetics in modern clinical recommendations for mbd-ckd - in the light of new studies using cincalcet» |
|
|
Zemchenkov A.
|
| 卷 16, 编号 2 (2024) |
The results of a multifactorial analysis to identify medical and social factors associated with the quality of life of patients with chronic kidney disease on hemodialysis |
|
|
Kotenko O., Abolyan L., Kuteinikov V., Arsanukaev I., Dorofeeeva E., Vinogradov V.
|
| 编号 5 (2013) |
Valganciclovir in cytomegalovirus prophylaxis in renal transplant recipients |
|
|
Prokopenko E., Shcherbakova E., Vatazin A., Yankovski A., Pasov S., Stepanov V., Artemov D.
|
| 编号 2 (2012) |
Recombinant human erythropoietin: original preparations and biological analogues |
|
|
Ermolenko V., Filatova N., Mikhaylova N., Khasabov N., Ermolenko V., Filatova N., Mikhailova N., Khasabov N.
|
| 卷 16, 编号 3 (2024) |
ISPD guidelines on catheter-associated infections 2023 |
|
|
Chow K., Li P., Cho Y., Abu-Alfa A., Bavanandan S., Brown E., Cullis B., Edwards D., Ethier I., Hurst H., Ito Y., Proenc´a de Moraes T., Morelle J., Runnegar N., Saxena A., So S., Tian N., Johnson D.
|
| 卷 14, 编号 4 (2022) |
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment |
|
|
Philip Kam-Tao Li -., Kai Ming Chow -., Yeoungjee Cho -., Stanley Fan -., Ana E Figueiredo -., Tess Harris -., Talerngsak Kanjanabuch -., Yong-Lim Kim -., Magdalena Madero -., Jolanta Malyszko -., Rajnish Mehrotra -., Ikechi G Okpechi -., Jeff Perl -., Beth Piraino -., Naomi Runnegar -., Isaac Teitelbaum -., Jennifer Ka-Wah Wong -., Xueqing Yu -., David W Johnson -.
|
| 编号 4 (2010) |
REKOMENDATsII EVROPEYSKOGO OBShchESTVA PO ARTERIAL'NOY GIPERTENZII VERSII 2009 GODA: ChTO IZMENILOS'? |
|
|
Chazova I., Fomin V.
|
| 编号 5 (2014) |
Reconstruction of ureteropelvic junction of allotransplantated kidney using contralateral ureter |
|
|
Sinyutin A., Yankovoy A., Smolyakov A., Granki V.
|
| 编号 5 (2011) |
Recormon: 20 years of success in clinical practice |
|
|
Ermolenko V., Filatova N.
|
| 编号 1 (2012) |
LEFT VENTRICULAR REMODELING IN PERITONEAL DYALISIS PATIENTS |
|
|
Vetchinnikova O., Pronina V., Pronina M., Kantariya R., Vetchinnikova O., Pronina V., Pronina N., Kantarya R.
|
| 编号 2 (2015) |
Renal osteodystrophy: initioal events |
|
|
Ermolenko V.
|
| 编号 5 (2011) |
Nephroprotective effect of angiotensin-converting enzyme inhibitors in children with Alport syndrome |
|
|
Kon'kova N., Ignatova M., Dlin V.
|
| 编号 6 (2013) |
Ischemia-reperfusion injury of kidney transplant: approaches to treatment and prevention |
|
|
Krstich M., Zul'karnaev A., Gubarev K., Fediunin A.
|
| 编号 4 (2011) |
Retsenziya na tret'e izdanie rukovodstva dlya vrachey «Detskaya nefrologiya» (pod redaktsiey M.S.Ignatovoy M. OOO «Meditsinskoe informatsionnoe agentstvo», 2011; 696 s) |
|
|
Rusnak F.
|
| 编号 1 (2009) |
RIChARD BRAYT (K 150-letiyu osnovnoy raboty, polozhivshey nachalo nefrologii) |
|
|
Tareev E.
|
| 卷 16, 编号 2 (2024) |
Roxadustat: treatment of anemia and additional clinical effects (literature review) |
|
|
Mikhailova N.
|
| 编号 6 (2010) |
ROLE OF STRUCTURAL AND FUCNTIONAL DESTABILIZATION OF NEPHROCYTE MEMBRANES IN PROGRESSION OF PYELONEPHRITIS |
|
|
Arkhipov E., Sigitova O.
|
| 编号 1 (2019) |
The role of ICAM-1 and a number of clinical and morphological factors in the development of tubulointerstitial fibrosis in chronic glomerulonephritis |
|
|
Bayandurova K., Batyushin M., Sarvilina I., Antipova N., Sinelnik E.
|
| 编号 4 (2010) |
ROL' AL'DOSTERONA V PORAZhENII POChEK PRI METABOLIChESKOM SINDROME, ASSOTsIIROVANNOM S OZhIRENIEM |
|
|
Kutyrina I., Kryachkova A., Savel'eva S., Shestakova M.
|
| 编号 3 (2014) |
Biomarkers in assessment of renal involvement in patients with arterial hypertension |
|
|
Kraidashenko O., Dolinnaya M.
|
| 编号 6 (2011) |
Role of ADAMTS13 deficiency in development of renal microcirculatory tromboses, not associated with thrombotic, thrombocytopenic purpura |
|
|
Kozlovskaya N., Khafizova E., Bobrova L., Bobkova I., Kuchieva A., Varshavskiy V., Stolyarevich E., Avdonin P., Zakharova E.
|
| 编号 5-6 (2012) |
Interleukin-6 in development of ishemia-reperfusion syndorme and renal transplant rejection |
|
|
Vatazin A., Zul'karnaev A., Astakhov P., Vasilenko I., Krstich M., Artemov D.
|
| 编号 5-6 (2015) |
The role of leptin in the pathogenesis of malnutrition in chronic hemodialysis patients |
|
|
Jakovenko A., Esajan A., Rumjancev A., Somova V.
|
| 编号 4 (2013) |
Matrix metalloproteinases in priogression of hereditary kidney disease |
|
|
Bashirova Z.
|
| 编号 4 (2013) |
Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases |
|
|
Eraliev A., Demeubaeva D., Naushabaeva A., Kabulbaev K., Chingaeva G., Abeouva B., Dosym S., Kanatbaeva A.
|
| 编号 6 (2011) |
Role of omega-3 unsaturated fatty acids in treatment of progressive kidney diseases |
|
|
Kulina E.
|
| 编号 1 (2012) |
Role of R990G polymorphism of calcium-sensing receptor gene in regulation of parathyroid hormone level in children with chronic kidney disease stage III-V |
|
|
Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumyantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosyan E., Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumiantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosian E.
|
| 卷 12, 编号 2 (2020) |
The role of patient’s adherence in the treatment of hyperphosphatemia in chronic kidney disease |
|
|
Esayan A., Rind A.
|
| 编号 5 (2013) |
Role of plant medicines in treatment of renal diseases |
|
|
Bratchikov O.
|
| 编号 2 (2015) |
The role of extracorporeal membrane oxygenation in modern medicine and its prospects in organ donation |
|
|
Stepanov V., Korshunov K., Jankovoj A.
|
| 卷 13, 编号 2 (2021) |
The role of oxidative stress in the development of protein-energy wasting and sarcopenia in patients with stage 5D chronic kidney disease |
|
|
Gasanov M., Negoda V., Batyushin M.
|
| 编号 1 (2019) |
Clinical practice guidelines for peritoneal dialysis in patients with chronic kidney disease stage 5 (CKD 5) |
|
|
Shutov E., Kotenko O.
|
| 601 - 700 的 915 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
